5 Results
Sort By:
Published on January 4, 2023
Direct acting oral anticoagulants (DOACs) are more cost-effective than low molecular weight heparin (LMWH) injections for the treatment of cancer-associated thrombosis, shows a new study published in the Annals of Internal Medicine. The findings “should help policymakers and clinicians with decision-making,” when considering the most suitable treatment for these patients,…
Published on February 7, 2024
A large Swedish study has shown that people undergoing surgery for cancer have an increased risk for venous thromboembolism (VTE) that persists for about two to four months postoperatively but varies by cancer type. “The results highlight the need for individualized venous thromboembolism risk evaluation and prophylaxis regimens for patients…
Published on May 17, 2022
New guidelines published by the American Heart and Stroke Associations for intracerebral hemorrhage (ICH) patients take into account new findings to improve outcomes and better tailor patient care. ICH, or bleeding stroke, accounts for around 10% of strokes (aprx. 80,000 events) in the U.S. each year. Fast and effective care,…
Published on March 15, 2023
German study data show that creating a small flap in the peritoneum during prostate cancer surgery can substantially reduce the rate of lymphoceles, a common post-operative complication where lymphatic fluid collects in the pelvis. The procedure is “safe, easy and inexpensive and should therefore be considered the new standard of…
Published on December 1, 2021
The second year of the COVID-19 pandemic continued to dominate headlines, and the roll out of numerous vaccines in the U.S. and around the world promised to help slow the spread of the virus. Yet despite the disruptions to research and in-person medical care, areas of precision medicine made advances…